Skip to content
The Great News – Lifestyle
Home
Sample Page
Author:
Annexon Biosciences
Annexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week
August 6, 2026
Annexon Secures Strategic Credit Facility for up to $200 Million from Oxford Finance
July 30, 2026
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
July 16, 2026
Annexon to Present Phase 2 ARCHER Baseline Characteristics Associated with Confirmed Best Corrected Visual Acuity 15-Letter Loss in Patients with Geographic Atrophy at ASRS 2026
July 14, 2026
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
June 16, 2026
Annexon to Participate in Upcoming June Investor Conferences
May 27, 2026
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
May 18, 2026
←
Previous Page
1
2